Stejbach Mark 4
4 · Flexion Therapeutics Inc · Filed Jun 21, 2018
Insider Transaction Report
Form 4
Stejbach Mark
Director
Transactions
- Award
Stock option (right to buy)
2018-06-20+12,500→ 12,500 totalExercise: $28.14Exp: 2028-06-19→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.